C2i Genomics

La solution de C2i utilise une plateforme cloud pour effectuer une surveillance globale de la charge tumorale cancéreuse en s'appuyant sur un réseau existant de séquenceurs de génomes dans le monde entier.

Pays

Israel

Site web

c2i-genomics.com

Fondé en

2019

Réseaux sociaux

Source d'information :

c2i-genomics.com , IVC-Online

Ajouter à ma liste

Equipes dirigeantes

Ezra Sofer

CEO and Co-founder

Dr. Boris Oklander

CTO and Co-founder

Dr. Asaf Zviran

Co-Founder

Industries

Biotech

Ajoutez votre entreprise

Disclaimer

The content of this website is not directed at or intended for persons in the United Kingdom or any other jurisdiction where the provision of the website or services would breach any applicable law or registration or would require any registration or license in any such jurisdiction. The content of this website should not be regarded as an invitation or inducement to engage in investment activity, to any person in the United Kingdom and investment opportunities described on this website are not intended to be acted upon by any persons in the United Kingdom.